Showing results (251-260 of 378) with videos related to
Sort By:
Pageof 38
European Urology|March 12, 2016
Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate CancerPasquale Rescigno, David Lorente, Diletta Bianchini, et al.The New England Journal of Medicine|April 20, 2012
Radiotherapy with or without chemotherapy in muscle-invasive bladder cancerNicholas D James, Syed A Hussain, Emma Hall, et al.International Journal of Radiation Oncology, Biology, Physics|August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice GuidelinesSun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.The Lancet. Oncology|February 4, 2021
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trialsAnanya Choudhury, Nuria Porta, Emma Hall, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2024
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate CancerSusan Halabi, Akash Roy, Larysa Rydzewska, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Prognostic Impact of Prostate-Specific Antigen at 6 Months After Radiotherapy in Localized Prostate Cancer: An Individual Patient Data Analysis of Randomized TrialsLucia Kwak, Praful Ravi, John G Armstrong, et al.European Urology|January 6, 2020
The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the TestisMichael Cullen, Robert Huddart, Johnathan Joffe, et al.International Journal of Cancer|November 4, 2004
Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 yearsMartin J Slade, Anjana Singh, Brendan M Smith, et al.The Lancet. Oncology|March 4, 2014
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trialDavid P Dearnaley, Gordana Jovic, Isabel Syndikus, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2021
Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional RegistrySophie R de Mol van Otterloo, John P Christodouleas, Erwin L A Blezer, et al.Pageof 38